NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces that it ...
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise ...
PLACEHOLDER, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG)(OTCQX: BNIGF) (“Beroni” or the “Company”) and Zhengzhou Jinshui Science & Education Park (“Jinshui Park”) have signed a ...
Type: Modified nanobody capable of treating coronaviruses, not only SARS-CoV-2 but the coronaviruses linked to SARS and MERS Status: Beroni Group on August 4 said its researchers and investigators ...
NEW YORK and SYDNEY, Australia, Oct. 24, 2019 (GLOBE NEWSWIRE) -- In April 2019, Beroni Group Limited (“Beroni” or the “Company”) (NSX: BTG; OTCQX: BNIGF) signed an exclusive license agreement with ...
Beroni China has signed a distribution agreement with a large online retailer in Guangzhou, China early this year to distribute the ODd Beroni Facial Care Series products. It is also selling the ...
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based ...
NEW YORK and SYDNEY, June 01, 2022 (GLOBE NEWSWIRE) -- Beroni Group (BNIGF) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced that it has received notification from its European ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results